Ovarian cancer risk in women with BRCA1/2 genetic variants

In this interview, Dr. Melissa Walker discusses management of ovarian cancer risk in women with BRCA1/2 pathogenic variants. She talks about risk factors for ovarian cancer, who should get genetic testing and who should get preventive surgery. She also discusses what to do about contraception and how to manage menopause in women with BRCA1/2. Dr. Melissa Walker is a fifth-year resident in obstetrics and gynecology at the University of Toronto. She works at Women’s College Hospital at the Preventive Ovarian Cancer Clinic in Toronto, Ontario. She co-authored a practice article with Dr. Michelle Jacobson and Dr. Mara Sobel published in the Canadian Medical Association Journal. Full article: www.cmaj.ca/lookup/doi/10.1503/cmaj.190281 Podcast transcript: //www.cmaj.ca/transcript-190281 ---------------------------------------------------------------------- This podcast episode is brought to you by Audi Canada. The Canadian Medical Association has partnered with Audi Canada to offer CMA members a preferred incentive on select vehicle models. Purchase any new qualifying Audi model and receive an additional cash incentive based on the purchase type. Details of the incentive program can be found at www.audiprofessional.ca. ----------------------------------- Subscribe to CMAJ Podcasts on Apple Podcasts or your favourite podcast app. You can also follow us directly on our SoundCloud page or you can visit www.cmaj.ca/page/multimedia/podcasts.